Editas Medicine, Inc. (0IFK.L)

USD 1.02

(0.22%)

Eps Summary of Editas Medicine, Inc.

  • Editas Medicine, Inc.'s latest annual eps in 2023 was -2.02 USD , up 32.21% from previous year.
  • Editas Medicine, Inc.'s latest quarterly eps in 2024 Q2 was -0.82 USD , down -7.89% from previous quarter.
  • Editas Medicine, Inc. reported an annual eps of -2.98 USD in 2022, down -8.76% from previous year.
  • Editas Medicine, Inc. reported an annual eps of -2.74 USD in 2021, down -46.52% from previous year.
  • Editas Medicine, Inc. reported a quarterly eps of -0.82 USD for 2024 Q2, down -7.89% from previous quarter.
  • Editas Medicine, Inc. reported a quarterly eps of -0.75 USD for 2024 Q3, up 8.54% from previous quarter.

Annual Eps Chart of Editas Medicine, Inc. (2023 - 2013)

Historical Annual Eps of Editas Medicine, Inc. (2023 - 2013)

Year Eps Eps Growth
2023 -2.02 USD 32.21%
2022 -2.98 USD -8.76%
2021 -2.74 USD -46.52%
2020 -1.87 USD 24.29%
2019 -2.47 USD -6.01%
2018 -2.33 USD 21.81%
2017 -2.98 USD 1.32%
2016 -3.02 USD -48.04%
2015 -2.04 USD -129.21%
2014 -0.89 USD 95.0%
2013 -17.80 USD 0.0%

Peer Eps Comparison of Editas Medicine, Inc.

Name Eps Eps Difference
uniQure N.V. -6.47 USD 68.779%
Agios Pharmaceuticals, Inc. -6.33 USD 68.088%
Amicus Therapeutics, Inc. -0.51 USD -296.078%
Atara Biotherapeutics, Inc. -65.18 USD 96.901%
bluebird bio, Inc. -1.93 USD -4.663%
Cara Therapeutics, Inc. -2.19 USD 7.763%
Imunon, Inc. -2.16 USD 6.481%
IQVIA Holdings Inc. 7.39 USD 127.334%
Mettler-Toledo International Inc. 36.10 USD 105.596%
Myriad Genetics, Inc. -1.39 USD -45.324%
Neurocrine Biosciences, Inc. 2.56 USD 178.906%
Supernus Pharmaceuticals, Inc. 0.02 USD 8481.743%
Verastem, Inc. -3.96 USD 48.99%
Walgreens Boots Alliance, Inc. -10.01 USD 79.82%
Waters Corporation 10.87 USD 118.583%
Thermo Fisher Scientific Inc. 15.53 USD 113.007%
Biogen Inc. 8.02 USD 125.187%
Nektar Therapeutics -1.45 USD -39.31%
Perrigo Company plc -0.09 USD -2051.225%
Dynavax Technologies Corporation -0.05 USD -3972.581%
Illumina, Inc. -7.35 USD 72.517%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 80.407%
Iovance Biotherapeutics, Inc. -1.89 USD -6.878%
Heron Therapeutics, Inc. -0.80 USD -152.5%
Unity Biotechnology, Inc. -2.70 USD 25.185%
BioMarin Pharmaceutical Inc. 0.89 USD 326.966%
Sangamo Therapeutics, Inc. -1.48 USD -36.486%
Evolus, Inc. -1.08 USD -87.037%
Adicet Bio, Inc. -3.31 USD 38.973%
Aclaris Therapeutics, Inc. -1.27 USD -59.055%
Regeneron Pharmaceuticals, Inc. 37.05 USD 105.452%
Esperion Therapeutics, Inc. -2.03 USD 0.493%
FibroGen, Inc. -2.92 USD 30.822%
Agilent Technologies, Inc. 4.22 USD 147.867%
OPKO Health, Inc. -0.25 USD -708.0%
Homology Medicines, Inc. -7.41 USD 72.74%
Geron Corporation -0.32 USD -531.25%
Alnylam Pharmaceuticals, Inc. -3.52 USD 42.614%
Exelixis, Inc. 0.65 USD 410.769%
Viking Therapeutics, Inc. -0.91 USD -121.978%
Anavex Life Sciences Corp. -0.60 USD -236.667%
Intellia Therapeutics, Inc. -5.42 USD 62.731%
Zoetis Inc. 5.08 USD 139.764%
Axsome Therapeutics, Inc. -5.27 USD 61.67%
Abeona Therapeutics Inc. -2.53 USD 20.158%
Vertex Pharmaceuticals Incorporated 14.05 USD 114.377%
Kala Pharmaceuticals, Inc. -17.35 USD 88.357%
Ionis Pharmaceuticals, Inc. -2.56 USD 21.094%
Sarepta Therapeutics, Inc. -5.80 USD 65.172%
Corcept Therapeutics Incorporated 1.02 USD 298.039%
Halozyme Therapeutics, Inc. 2.13 USD 194.836%
Blueprint Medicines Corporation -8.37 USD 75.866%
Insmed Incorporated -5.34 USD 62.172%
TG Therapeutics, Inc. 0.09 USD 2362.038%
Incyte Corporation 2.67 USD 175.655%
Emergent BioSolutions Inc. -14.85 USD 86.397%